Abstract
Guidelines on cervical cancer (CC) enable a series of recommendations and strategies for primary and secondary prevention, early diagnosis, in advanced stages, as well as treatment in various scenarios. The human papillomavirus (HPV) vaccine can reduce the development of cervical precancerous lesions. That will drastically lower the incidence rates of CC. The tool traditionally used for secondary prevention is cytology with the Papanicolaou staining technique. The CC treatment will be determined based on the initial stage: for early stages, it is based on surgical management; in locally advanced disease, treatment requires concomitant chemo - radiotherapy + brachytherapy (BT). Recent modifications in staging, standardization in surgical management, and various options for recurrence or metastatic disease have been added.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Latin american journal of clinical sciences and medical technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
